• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外膜肺氧合患儿连续性肾脏替代治疗中液体超负荷与液体清除。

Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy.

机构信息

Division of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA.

出版信息

Crit Care Med. 2012 Sep;40(9):2694-9. doi: 10.1097/CCM.0b013e318258ff01.

DOI:10.1097/CCM.0b013e318258ff01
PMID:22743776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3423554/
Abstract

OBJECTIVE

In pediatric patients, fluid overload at continuous renal replacement therapy initiation is associated with increased mortality. The aim of this study was to characterize the association between fluid overload at continuous renal replacement therapy initiation, fluid removal during continuous renal replacement therapy, the kinetics of fluid removal and mortality in a large pediatric population receiving continuous renal replacement therapy while on extracorporeal membrane oxygenation.

DESIGN

Retrospective chart review.

SETTING

Tertiary children's hospital.

PATIENTS

Extracorporeal membrane oxygenation patients requiring continuous renal replacement therapy from July 2006 to September 2010.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Overall intensive care unit survival was 34% for 53 patients that were initiated on continuous renal replacement therapy while on extracorporeal membrane oxygenation during the study period. Median fluid overload at continuous renal replacement therapy initiation was significantly lower in survivors compared to nonsurvivors (24.5% vs. 38%, p = .006). Median fluid overload at continuous renal replacement therapy discontinuation was significantly lower in survivors compared to nonsurvivors (7.1% vs. 17.5%, p = .035). After adjusting for percent fluid overload at continuous renal replacement therapy initiation, age, and severity of illness, the change in fluid overload at continuous renal replacement therapy discontinuation was not significantly associated with mortality (p = .212). Models investigating the rates of fluid removal in different periods, age, severity of illness, and fluid overload at continuous renal replacement therapy initiation found that fluid overload at continuous renal replacement therapy initiation was the most consistent predictor of survival.

CONCLUSIONS

Our data demonstrate an association between fluid overload at continuous renal replacement therapy initiation and mortality in pediatric patients receiving extracorporeal membrane oxygenation. The degree of fluid overload at continuous renal replacement therapy discontinuation is also associated with mortality, but appears to reflect the effect of fluid overload at initiation. Furthermore, correction of fluid overload to ≤ 10% was not associated with improved survival. These results suggest that intervening prior to the development of significant fluid overload may be more clinically effective than attempting fluid removal after significant fluid overload has developed. Our findings suggest a role for earlier initiation of continuous renal replacement therapy in this population, and warrant further clinical studies.

摘要

目的

在接受连续性肾脏替代治疗(CRRT)的儿科患者中,起始时的液体超负荷与死亡率增加有关。本研究的目的是描述在接受体外膜肺氧合(ECMO)的大量儿科患者中,CRRT 起始时的液体超负荷、CRRT 期间的液体清除量、液体清除动力学与死亡率之间的关联。

设计

回顾性图表审查。

地点

三级儿童医院。

患者

2006 年 7 月至 2010 年 9 月期间需要 ECMO 支持的接受 CRRT 的患者。

干预措施

无。

测量和主要结果

在研究期间,53 名接受 ECMO 支持的患者开始接受 CRRT,总体 ICU 生存率为 34%。与幸存者相比,非幸存者的 CRRT 起始时的液体超负荷中位数明显更高(24.5%对 38%,p=0.006)。与非幸存者相比,幸存者的 CRRT 停止时的液体超负荷中位数明显更低(7.1%对 17.5%,p=0.035)。在校正 CRRT 起始时的液体超负荷百分比、年龄和疾病严重程度后,CRRT 停止时液体超负荷的变化与死亡率无显著相关性(p=0.212)。在调查不同时间段、年龄、疾病严重程度和 CRRT 起始时液体超负荷的液体清除率的模型中,发现 CRRT 起始时的液体超负荷是生存的最一致预测因素。

结论

我们的数据表明,在接受 ECMO 的儿科患者中,CRRT 起始时的液体超负荷与死亡率相关。CRRT 停止时的液体超负荷程度也与死亡率相关,但似乎反映了起始时液体超负荷的影响。此外,将液体超负荷纠正至≤10%并未提高生存率。这些结果表明,在发生明显液体超负荷之前进行干预可能比在发生明显液体超负荷后进行液体清除更为有效。我们的发现表明,在该人群中更早开始 CRRT 可能具有作用,并需要进一步的临床研究。

相似文献

1
Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy.体外膜肺氧合患儿连续性肾脏替代治疗中液体超负荷与液体清除。
Crit Care Med. 2012 Sep;40(9):2694-9. doi: 10.1097/CCM.0b013e318258ff01.
2
Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study.需要持续肾脏替代治疗的接受体外膜肺氧合的儿科患者的液体超负荷与液体清除:一项多中心回顾性队列研究
Pediatr Nephrol. 2020 May;35(5):871-882. doi: 10.1007/s00467-019-04468-4. Epub 2020 Jan 17.
3
Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy.危重症儿童需要肾脏替代治疗的死亡风险因素。
Pediatr Crit Care Med. 2019 Nov;20(11):1069-1077. doi: 10.1097/PCC.0000000000002045.
4
Timing of continuous renal replacement therapy and mortality in critically ill children*.危重症儿童连续性肾脏替代治疗时机与死亡率的关系*。
Crit Care Med. 2014 Apr;42(4):943-53. doi: 10.1097/CCM.0000000000000039.
5
Mortality of Critically Ill Children Requiring Continuous Renal Replacement Therapy: Effect of Fluid Overload, Underlying Disease, and Timing of Initiation.危重症儿童连续肾脏替代治疗死亡率:液体超负荷、基础疾病和起始时机的影响。
Pediatr Crit Care Med. 2019 Apr;20(4):314-322. doi: 10.1097/PCC.0000000000001806.
6
The Impact of Fluid Overload on Outcomes in Children Treated With Extracorporeal Membrane Oxygenation: A Multicenter Retrospective Cohort Study.体外膜肺氧合治疗儿童中液体超负荷对结局的影响:一项多中心回顾性队列研究。
Pediatr Crit Care Med. 2017 Dec;18(12):1126-1135. doi: 10.1097/PCC.0000000000001349.
7
Factors Associated With Mortality in Continuous Renal Replacement Therapy for Pediatric Patients With Acute Kidney Injury.小儿急性肾损伤患者持续肾脏替代治疗中与死亡率相关的因素。
Pediatr Crit Care Med. 2017 Feb;18(2):e56-e61. doi: 10.1097/PCC.0000000000001024.
8
Acute Kidney Injury, Fluid Overload, and Renal Replacement Therapy Differ by Underlying Diagnosis in Neonatal Extracorporeal Support and Impact Mortality Disparately.急性肾损伤、液体超负荷和肾脏替代治疗因新生儿体外生命支持的基础诊断而异,并对死亡率有不同影响。
Blood Purif. 2021;50(6):808-817. doi: 10.1159/000512538. Epub 2021 Jan 18.
9
Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review.体外膜肺氧合与连续性肾脏替代疗法联合用于危重症患者:一项系统评价
Crit Care. 2014 Dec 8;18(6):675. doi: 10.1186/s13054-014-0675-x.
10
Continuous renal replacement therapy in children: fluid overload does not always predict mortality.儿童连续性肾脏替代治疗:液体超负荷并不总是预测死亡率。
Pediatr Nephrol. 2016 Apr;31(4):651-9. doi: 10.1007/s00467-015-3248-6. Epub 2015 Nov 12.

引用本文的文献

1
Optimising fluid therapy during venoarterial extracorporeal membrane oxygenation: current evidence and future directions.体外膜肺氧合期间优化液体治疗:当前证据与未来方向
Ann Intensive Care. 2025 Mar 19;15(1):32. doi: 10.1186/s13613-025-01458-8.
2
Arterial hypertension in infants with congenital diaphragmatic hernia following surgical repair.先天性膈疝修补术后婴儿动脉高血压。
Eur J Pediatr. 2024 Jul;183(7):2831-2842. doi: 10.1007/s00431-024-05509-3. Epub 2024 Apr 6.
3
Risk factors for mortality in surgical patients on combined continuous renal replacement therapy and extracorporeal membrane oxygenation: single-center retrospective study.

本文引用的文献

1
Weight-based determination of fluid overload status and mortality in pediatric intensive care unit patients requiring continuous renal replacement therapy.基于体重的液体超负荷状态判断与接受连续性肾脏替代治疗的儿科重症监护病房患者死亡率的相关性。
Intensive Care Med. 2011 Jul;37(7):1166-73. doi: 10.1007/s00134-011-2231-3. Epub 2011 Apr 30.
2
Acute kidney injury in congenital diaphragmatic hernia requiring extracorporeal life support: an insidious problem.先天性膈疝需要体外生命支持的急性肾损伤:一个隐伏的问题。
J Pediatr Surg. 2011 Apr;46(4):630-635. doi: 10.1016/j.jpedsurg.2010.11.031.
3
Timing of renal replacement therapy after cardiac surgery: a retrospective multicenter Spanish cohort study.
连续肾脏替代治疗和体外膜肺氧合联合治疗的外科患者死亡的危险因素:单中心回顾性研究。
Ren Fail. 2023;45(2):2282019. doi: 10.1080/0886022X.2023.2282019. Epub 2023 Nov 20.
4
Fluid assessment, fluid balance, and fluid overload in sick children: a report from the Pediatric Acute Disease Quality Initiative (ADQI) conference.患病儿童的液体评估、液体平衡及液体超负荷:来自儿科急性疾病质量改进计划(ADQI)会议的报告
Pediatr Nephrol. 2024 Mar;39(3):955-979. doi: 10.1007/s00467-023-06156-w. Epub 2023 Nov 7.
5
Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference.住院及危重症儿童儿科急性肾支持治疗的推进方案与流程:第26届急性疾病质量改进倡议(ADQI)共识会议报告
Pediatr Nephrol. 2024 Mar;39(3):993-1004. doi: 10.1007/s00467-023-06186-4. Epub 2023 Nov 6.
6
An update on the role of fluid overload in the prediction of outcome in acute kidney injury.液体超负荷在急性肾损伤预后预测中的作用的最新进展。
Pediatr Nephrol. 2024 Jul;39(7):2033-2048. doi: 10.1007/s00467-023-06161-z. Epub 2023 Oct 20.
7
Fluid Management in Veno-Arterial Extracorporeal Membrane Oxygenation Therapy-Analysis of an Experimental Pig Model.静脉-动脉体外膜肺氧合治疗中的液体管理——实验猪模型分析
J Clin Med. 2023 Aug 16;12(16):5330. doi: 10.3390/jcm12165330.
8
Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK).全球肾脏疾病肾脏替代治疗结局协作组(WE-ROCK)。
Kidney Int Rep. 2023 Jun 5;8(8):1542-1552. doi: 10.1016/j.ekir.2023.05.026. eCollection 2023 Aug.
9
Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units Across Europe.欧洲儿科重症监护病房中的连续肾脏替代治疗实践。
JAMA Netw Open. 2022 Dec 1;5(12):e2246901. doi: 10.1001/jamanetworkopen.2022.46901.
10
Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement.基于共识的儿童急性肾损伤重点活动推荐意见:改良 Delphi 共识声明。
JAMA Netw Open. 2022 Sep 1;5(9):e2229442. doi: 10.1001/jamanetworkopen.2022.29442.
心脏手术后肾脏替代治疗时机:回顾性多中心西班牙队列研究。
Blood Purif. 2011;32(2):104-11. doi: 10.1159/000324195. Epub 2011 Mar 2.
4
Current and future role of ultrafiltration in CRS.超滤在慢性肾脏病中的当前和未来作用。
Heart Fail Rev. 2011 Nov;16(6):595-602. doi: 10.1007/s10741-010-9198-y.
5
Cardiorenal syndrome: new perspectives.心肾综合征:新视角
Circulation. 2010 Jun 15;121(23):2592-600. doi: 10.1161/CIRCULATIONAHA.109.886473.
6
Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation.体外膜肺氧合期间连续肾脏替代治疗后肾功能的恢复和生存。
Pediatr Crit Care Med. 2011 Mar;12(2):153-8. doi: 10.1097/PCC.0b013e3181e2a596.
7
Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry.液体超负荷与连续性肾脏替代治疗患儿的死亡率:前瞻性儿科连续性肾脏替代治疗登记研究。
Am J Kidney Dis. 2010 Feb;55(2):316-25. doi: 10.1053/j.ajkd.2009.10.048. Epub 2009 Dec 30.
8
Cardiorenal syndrome in children with heart failure.心力衰竭患儿的心肾综合征
Curr Heart Fail Rep. 2009 Sep;6(3):191-8. doi: 10.1007/s11897-009-0027-3.
9
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.急性肾损伤危重症患者的液体蓄积、生存情况及肾功能恢复
Kidney Int. 2009 Aug;76(4):422-7. doi: 10.1038/ki.2009.159. Epub 2009 May 13.
10
The use of renal replacement therapy in acute decompensated heart failure.肾脏替代疗法在急性失代偿性心力衰竭中的应用。
Semin Dial. 2009 Mar-Apr;22(2):173-9. doi: 10.1111/j.1525-139X.2008.00542.x.